Clinical Trial Update: Heterogeneity of Diabetes: Integrated Muli-Omics to Identify Physiologic Subphenotypes and Evaluate Targeted Prevention [Phase 4]

View source ↗

Summary

This Phase 4 clinical study from Stanford investigates the heterogeneity of diabetes using integrated multi-omics to identify physiologic subphenotypes and eval…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prediabetes
• Type 2 Diabetes Mellitus

Snippet

Sponsor: Stanford University | Conditions: Prediabetes / Type 2 Diabetes | Phase 4 | Status: NOT_YET_RECRUITING